Cargando…

Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial

BACKGROUND: For decades, the research community has called for participant information sheets/consent forms (PICFs) to be improved. Recommendations include simplifying content, reducing length, presenting information in layers and using multimedia. However, there are relatively few studies that have...

Descripción completa

Detalles Bibliográficos
Autores principales: Symons, Tanya J., Straiton, Nicola, Gagnon, Rosie, Littleford, Roberta, Campbell, Anita J., Bowen, Asha C., Stewart, Adam G., Tong, Steven Y. C., Davis, Joshua S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795139/
https://www.ncbi.nlm.nih.gov/pubmed/36578070
http://dx.doi.org/10.1186/s13063-022-07023-z
_version_ 1784860190497046528
author Symons, Tanya J.
Straiton, Nicola
Gagnon, Rosie
Littleford, Roberta
Campbell, Anita J.
Bowen, Asha C.
Stewart, Adam G.
Tong, Steven Y. C.
Davis, Joshua S.
author_facet Symons, Tanya J.
Straiton, Nicola
Gagnon, Rosie
Littleford, Roberta
Campbell, Anita J.
Bowen, Asha C.
Stewart, Adam G.
Tong, Steven Y. C.
Davis, Joshua S.
author_sort Symons, Tanya J.
collection PubMed
description BACKGROUND: For decades, the research community has called for participant information sheets/consent forms (PICFs) to be improved. Recommendations include simplifying content, reducing length, presenting information in layers and using multimedia. However, there are relatively few studies that have evaluated health consumers’ (patients/carers) perspectives on the type and organisation of information, and the level of detail to be included in a PICF to optimise an informed decision to enter a trial. We aimed to elicit consumers’ views on a layered approach to consent that provides the key information for decision-making in a short PICF (layer 1) with additional optional information that is accessed separately (layer 2). We also elicited consumers’ views on the optimal content and layout of the layered consent materials for a large and complex Bayesian adaptive platform trial (the SNAP trial). METHODS: We conducted a qualitative multicentre study (4 focus groups and 2 semi-structured interviews) involving adolescent and adult survivors of Staphylococcus aureus bloodstream infection (22) and their carers (2). Interview transcripts were examined using inductive thematic analysis. RESULTS: Consumers supported a layered approach to consent. The primary theme that emerged was the value of agency; the ability to exert some control over the amount of information read before the consent form is signed. Three other themes emerged; the need to prioritise participants’ information needs; the importance of health literacy; the importance of information about a trial’s benefits (over its risks) for decision-making and the interplay between the two. CONCLUSIONS: Our findings suggest that consumers may challenge the one-size-fits-all approach currently applied to the development of PICFs in countries like Australia. Consumers supported a layered approach to consent that offers choice in the amount of information to be read before deciding whether to enter a trial. A 3-page PICF was considered sufficient for decision-making for the SNAP trial, provided that further information was available and accessible. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-07023-z.
format Online
Article
Text
id pubmed-9795139
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97951392022-12-28 Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial Symons, Tanya J. Straiton, Nicola Gagnon, Rosie Littleford, Roberta Campbell, Anita J. Bowen, Asha C. Stewart, Adam G. Tong, Steven Y. C. Davis, Joshua S. Trials Research BACKGROUND: For decades, the research community has called for participant information sheets/consent forms (PICFs) to be improved. Recommendations include simplifying content, reducing length, presenting information in layers and using multimedia. However, there are relatively few studies that have evaluated health consumers’ (patients/carers) perspectives on the type and organisation of information, and the level of detail to be included in a PICF to optimise an informed decision to enter a trial. We aimed to elicit consumers’ views on a layered approach to consent that provides the key information for decision-making in a short PICF (layer 1) with additional optional information that is accessed separately (layer 2). We also elicited consumers’ views on the optimal content and layout of the layered consent materials for a large and complex Bayesian adaptive platform trial (the SNAP trial). METHODS: We conducted a qualitative multicentre study (4 focus groups and 2 semi-structured interviews) involving adolescent and adult survivors of Staphylococcus aureus bloodstream infection (22) and their carers (2). Interview transcripts were examined using inductive thematic analysis. RESULTS: Consumers supported a layered approach to consent. The primary theme that emerged was the value of agency; the ability to exert some control over the amount of information read before the consent form is signed. Three other themes emerged; the need to prioritise participants’ information needs; the importance of health literacy; the importance of information about a trial’s benefits (over its risks) for decision-making and the interplay between the two. CONCLUSIONS: Our findings suggest that consumers may challenge the one-size-fits-all approach currently applied to the development of PICFs in countries like Australia. Consumers supported a layered approach to consent that offers choice in the amount of information to be read before deciding whether to enter a trial. A 3-page PICF was considered sufficient for decision-making for the SNAP trial, provided that further information was available and accessible. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-07023-z. BioMed Central 2022-12-28 /pmc/articles/PMC9795139/ /pubmed/36578070 http://dx.doi.org/10.1186/s13063-022-07023-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Symons, Tanya J.
Straiton, Nicola
Gagnon, Rosie
Littleford, Roberta
Campbell, Anita J.
Bowen, Asha C.
Stewart, Adam G.
Tong, Steven Y. C.
Davis, Joshua S.
Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial
title Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial
title_full Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial
title_fullStr Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial
title_full_unstemmed Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial
title_short Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial
title_sort consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795139/
https://www.ncbi.nlm.nih.gov/pubmed/36578070
http://dx.doi.org/10.1186/s13063-022-07023-z
work_keys_str_mv AT symonstanyaj consumerperspectivesonsimplifiedlayeredconsentforalowriskbutcomplexpragmatictrial
AT straitonnicola consumerperspectivesonsimplifiedlayeredconsentforalowriskbutcomplexpragmatictrial
AT gagnonrosie consumerperspectivesonsimplifiedlayeredconsentforalowriskbutcomplexpragmatictrial
AT littlefordroberta consumerperspectivesonsimplifiedlayeredconsentforalowriskbutcomplexpragmatictrial
AT campbellanitaj consumerperspectivesonsimplifiedlayeredconsentforalowriskbutcomplexpragmatictrial
AT bowenashac consumerperspectivesonsimplifiedlayeredconsentforalowriskbutcomplexpragmatictrial
AT stewartadamg consumerperspectivesonsimplifiedlayeredconsentforalowriskbutcomplexpragmatictrial
AT tongstevenyc consumerperspectivesonsimplifiedlayeredconsentforalowriskbutcomplexpragmatictrial
AT davisjoshuas consumerperspectivesonsimplifiedlayeredconsentforalowriskbutcomplexpragmatictrial